Primary myelofibrosis and White blood cell count increased

Summary:

White blood cell count increased is found among people with Primary myelofibrosis, especially for people who are male, 60+ old.

The study analyzes which people have White blood cell count increased with Primary myelofibrosis. It is created by eHealthMe based on reports of 1,526 people who have Primary myelofibrosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 08, 2023

1,526 people who have Primary Myelofibrosis and White Blood Cell Count Increased are studied.

What is Primary myelofibrosis?

Primary myelofibrosis (primary disorder of the bone marrow) is found to be associated with 1,073 drugs and 753 conditions by eHealthMe.

What is White blood cell count increased?

White blood cell count increased is found to be associated with 2,850 drugs and 2,512 conditions by eHealthMe.

Number of White blood cell count increased in Primary myelofibrosis reports submitted per year:

Would you have White blood cell count increased when you have Primary myelofibrosis?

Gender of people who have Primary myelofibrosis and experienced White blood cell count increased *:

Click here to view

Age of people who have Primary myelofibrosis and experienced White blood cell count increased *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have White blood cell count increased?

Check whether White blood cell count increased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

Primary myelofibrosis (35,056 reports)
White blood cell count increased (50,251 reports)

COVID vaccines that are related to White blood cell count increased:

Common drugs associated with White blood cell count increased:

All the drugs that are associated with White blood cell count increased:

White blood cell count increased (2,850 drugs)

Common conditions associated with White blood cell count increased:

All the conditions that are associated with White blood cell count increased:

White blood cell count increased (2,512 conditions)

How the study uses the data?

The study is based on White blood cell count increased and Primary myelofibrosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.